CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 83 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2018. The put-call ratio across all filers is 2.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $359,000 | +23.4% | 3,511 | +40.4% | 0.20% | +488.2% |
| Q4 2019 | $291,000 | +1.7% | 2,500 | 0.0% | 0.03% | -12.8% |
| Q3 2019 | $286,000 | -81.9% | 2,500 | -84.3% | 0.04% | -50.0% |
| Q2 2018 | $1,579,000 | -32.6% | 15,900 | -45.0% | 0.08% | -37.1% |
| Q1 2018 | $2,342,000 | +5.4% | 28,910 | +2.5% | 0.12% | -8.1% |
| Q4 2017 | $2,221,000 | +86.3% | 28,200 | +118.4% | 0.14% | +66.7% |
| Q3 2017 | $1,192,000 | – | 12,915 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 137,557 | $11,142,000 | 6.62% |
| COMGEST GLOBAL INVESTORS S.A.S. | 637,752 | $51,658,000 | 1.13% |
| Black Creek Investment Management Inc. | 411,525 | $33,334,000 | 1.09% |
| Hillhouse Capital Management | 618,391 | $50,090,000 | 0.88% |
| RUDMAN ERROL M | 21,301 | $1,725,000 | 0.83% |
| JUPITER ASSET MANAGEMENT LTD | 263,705 | $21,360,000 | 0.65% |
| York Capital Management Global Advisors, LLC | 341,616 | $27,671,000 | 0.62% |
| VONTOBEL ASSET MANAGEMENT INC | 873,968 | $71,525,000 | 0.51% |
| Temasek Holdings (Private) Ltd | 990,000 | $80,190,000 | 0.44% |
| WASATCH ADVISORS LP | 292,216 | $23,669,000 | 0.31% |